Endometriosis-associated pain control by contraceptive implant or intrauterine system
Etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system have similar therapeutic effects in women with endometriosis-associated pelvic pain.
Key Points Lay Summary
Factors related to delay in endometriosis diagnosis
Could delays in endometriosis diagnosis be avoided?
Key Points Lay Summary
Does the presence of endometriosis increase the risk of gynecologic malignancies?
Endometriosis and risk of ovarian, endometrial, and cervical cancers
Key Points Lay Summary
Extragenital endometriosis and ultrasound
Contrast-enhanced ultrasound is an efficient non-invasive imaging technique that is helpful in the early diagnosis of intestinal endometriosis.
Key Points Lay Summary
Lipophilic Statins inhibit growth and invasiveness of human endometrial cells
Statins may be potential medication to decrease proliferation and invasiveness of endometrial cells
Key Points Lay Summary
Can we Inhibit the Survival of Endometriosis?
ERK1/2 and AKT Pathways in Endometriosis
Key Points Lay Summary
Sexual distress, metacognitive beliefs, and endometriosis
Cognitions about own worries plays the most important role in the prediction of sexual distress.
Key Points Lay Summary
Pelvic pain, congenital genital tract anomalies and endometriosis
The early diagnosis-management of congenital genital tract anomalies prevent the development of pelvic endometriosis and infections.
Key Points Lay Summary